The Post-hospitalisation COVID-19 study (PHOSP-COVID)

A consortium of leading researchers and clinicians from across the UK working together to understand and improve long-term health outcomes for patients who have been in hospital with confirmed or suspected COVID-19.

Read more

As we emerge from the first wave of the pandemic, we have new insights into the sudden onset phase of this disease but there is very little information concerning the long-term effects of COVID-19 and what the ongoing medical, psychological and rehabilitation needs for this group of patients will be to enable them to make as full a recovery as possible.

Chris Brightling, Professor of Respiratory Medicine and Chief Investigator for PHOSP-COVID

Watch now

To address this gap in our understanding, PHOSP-COVID has been set up and funded as a long term research study to recruit 10,000 patients who have been hospitalised with COVID-19. Over the course of a year, clinical assessments will track patients to gain a comprehensive picture of the impact COVID-19 has had on longer term health outcomes across the UK.

The PHOSP-COVID team will then develop trials of new strategies for clinical care, including personalised treatments for groups of patients based on the particular disease characteristics they show as a result of having COVID-19 to improve their long term health.